AngioDynamics, Inc.ANGONASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -7.88% | -4.23% | +12.93% | +12.18% | +9.04% |
| Gross Profit Growth | -0.88% | +8.35% | +9.61% | +13.98% | +5.60% |
| EBITDA Growth | +0.00% | +0.00% | +117.39% | +0.00% | -124.32% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.75% | +1.54% | +1.38% | +1.28% | +1.18% |
| Weighted Average Shares Diluted Growth | +1.75% | +1.54% | +1.38% | +1.28% | +1.18% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -53.04% | +0.00% | +276.14% | +0.00% | +88.48% |
| Free Cash Flow Growth | -64.43% | +0.00% | +306.63% | +0.00% | +152.92% |
| Receivables Growth | -16.37% | -1.02% | -13.74% | +7.79% | +2.96% |
| Inventory Growth | +2.59% | +8.67% | +2.29% | -3.78% | -0.53% |
| Asset Growth | -41.65% | -12.14% | -11.81% | -9.53% | -7.50% |
| Book Value per Share Growth | -54.25% | -16.30% | -12.21% | -10.17% | -6.69% |
| Debt Growth | +0.00% | +0.00% | -100.00% | -100.00% | -100.00% |
| R&D Expense Growth | -25.69% | -15.58% | -1.99% | +2.10% | +20.73% |
| SG&A Expenses Growth | +3.53% | +0.03% | +4.71% | +11.22% | +2.45% |